Multiple Sclerosis Drugs Market Outlook 2024-2028, 2033 - A $48 Billion Global Opportunity Dominated by Biogen, Novartis, Roche, Bayer HealthCare, and Pfizer
16 mai 2024 08h00 HE
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global multiple sclerosis drugs...
Global Multiple Sclerosis Treatment Market Report 2023: Sector is Projected to Reach $38.41 Million in 2031 at a CAGR of 4.3%
03 mai 2023 10h53 HE
|
Research and Markets
Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global...
Multiple Sclerosis Drugs Market Size Forecast [2022-2028] | is Projected to Reach USD 41.99 Billion, Exhibiting a CAGR of 6.3 %
19 janv. 2022 03h53 HE
|
Fortune Business Insights
Pune, India, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
North American MS Drugs Market, Forecast to 2027 by Drug Type, Class & Category; RoA; MS Type; Distribution Channel; and Country
15 déc. 2021 08h53 HE
|
Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "North America Multiple Sclerosis Drugs Market 2020-2027" report has been added to ResearchAndMarkets.com's offering. The North American multiple...
Global Multiple Sclerosis Drugs Market Report 2021: Market is Expected to Reach $25.95 Billion in 2025 - Long-term Forecast to 2030
13 déc. 2021 06h53 HE
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Multiple Sclerosis Drugs Market (2020 to 2027) - Focus on Immunomodulators and Immunosuppressants
10 déc. 2021 06h38 HE
|
Research and Markets
Dublin, Dec. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Drugs Market 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global multiple sclerosis drugs...
Multiple Sclerosis Drugs Market to Reach USD 41.99 Billion by 2028 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast To 2028
08 nov. 2021 03h56 HE
|
Fortune Business Insights
Pune, India, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
Multiple Sclerosis Drugs Market Size 2021-2028 | To Reach USD 41.99 Billion by 2028, Exhibiting a CAGR of 6.3 %
05 juil. 2021 05h37 HE
|
Fortune Business Insights
Pune, India, July 05, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
Multiple Sclerosis Drugs Market to Reach USD 41.99 Billion by 2028; Rising Support from Governments and Launch of Awareness Initiatives to Aid Growth: Fortune Business Insights™
10 juin 2021 07h34 HE
|
Fortune Business Insights
Pune, India, June 10, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
Worldwide Multiple Sclerosis Therapeutics Industry to 2027 - by Drug Class, Route of Administration, and Distribution Channel and Geography
14 avr. 2021 05h08 HE
|
Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class, Route of Administration, and Distribution...